Lam Research (LRCX) Cash & Equivalents (2009 - 2026)

Lam Research's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $4.8 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 12.84% year-over-year to $4.8 billion; the TTM figure through Mar 2026 stood at $4.8 billion (down 12.84% YoY), while the FY2025 annual figure was $6.4 billion, up 9.28% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $4.8 billion, down from $6.2 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $6.7 billion in Q3 2025, with the low at $3.5 billion in Q2 2022.
• The 5-year median for Cash & Equivalents is $5.5 billion (2025), against an average of $5.3 billion.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents declined 20.29% in 2022, then surged 51.53% in 2023.
• Lam Research's Cash & Equivalents stood at $4.5 billion in 2022, then rose by 25.39% to $5.6 billion in 2023, then advanced by 0.75% to $5.7 billion in 2024, then rose by 9.09% to $6.2 billion in 2025, then dropped by 23.13% to $4.8 billion in 2026.
• Business Quant data shows LRCX's Cash & Equivalents at $4.8 billion in Q1 2026, $6.2 billion in Q4 2025, and $6.7 billion in Q3 2025.